HTA; medtech; evidence

For sponsors seeking public reimbursement in Australia, submissions for diagnostic and investigative technologies present a fundamentally different challenge to therapeutic services. Under the Medical Services Advisory Committee (MSAC) framework, diagnostic…

For medical device companies seeking reimbursement in the Australian private hospital system, inclusion on the Prescribed List (PL) remains critical. What has changed is that the Prescribed List is no…